Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Geert Maertens"'
Autor:
Piotr Rutkowski, Patrick Pauwels, Joseph Kerger, Bart Jacobs, Geert Maertens, Valerie Gadeyne, Anne Thielemans, Katrien de Backer, Bart Neyns
Publikováno v:
Cancers, Vol 13, Iss 14, p 3591 (2021)
Tissue-based tests for BRAFV600 mutation-positive melanoma involve invasive biopsy procedures, and can lead to an erroneous diagnosis when the tumor samples degrade. Herein, we explored a minimally invasive, cell-free deoxyribonucleic acid (cfDNA)-ba
Externí odkaz:
https://doaj.org/article/24f9a23e43244cfab362f87bf433b3cd
Autor:
Leda BASSIT, Luiz C. DA SILVA, Gabriela RIBEIRO-DOS-SANTOS, Geert MAERTENS, Flair J. CARRILHO, Luis E. P. FONSECA, Venâncio A. F. ALVES, Luis C.C. GAYOTTO, Analice N. PEREIRA, Kioko TAKEI, Dalton CHAMONE, Amadeo SÁEZ-ALQUÉZAR
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 41, Iss 3, Pp 183-189 (1999)
The present study assessed the clinical significance of hepatitis C virus (HCV) genotypes and their influence on response to long term recombinant-interferon-alpha (r-IFN-a) therapy in Brazilian patients. One hundred and thirty samples from patients
Externí odkaz:
https://doaj.org/article/558220bc66e542478674d7414eaa556a
Autor:
Anne J M Loonen, Martine P Bos, Bart van Meerbergen, Sigi Neerken, Arnold Catsburg, Irene Dobbelaer, Roel Penterman, Geert Maertens, Paul van de Wiel, Paul Savelkoul, Adriaan J C van den Brule
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72349 (2013)
For patients suffering from bloodstream infections (BSI) molecular diagnostics from whole blood holds promise to provide fast and adequate treatment. However, this approach is hampered by the need of large blood volumes. Three methods for pathogen DN
Externí odkaz:
https://doaj.org/article/0374e4ca36a64227beb77c312fa4aa47
Autor:
Funda Meric-Bernstam, Razelle Kurzrock, Gordon B. Mills, Geert Maertens, Erwin Sablon, Benoit Devogelaere, Sapna Patel, Bryan K. Kee, Michael J. Overman, Scott Kopetz, Rajyalakshmi Luthra, Vivek Subbiah, Ralph G. Zinner, Veronica R. Holley, Daniel D. Karp, Jennifer J. Wheler, Sarina A. Piha-Paul, Aung Naing, Apostolia M. Tsimberidou, Goran Cabrilo, Giovanni Nitti, Nishma M. Ramzanali, David Hong, Siqing Fu, Gerald S. Falchook, Bart Claes, Helen J. Huang, Filip Janku
Cell-free (cf) DNA from plasma offers an easily obtainable material for BRAF mutation analysis for diagnostics and response monitoring. In this study, plasma-derived cfDNA samples from patients with progressing advanced cancers or malignant histiocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ef94582c1c6f3d6a2f4d621403ca07
https://doi.org/10.1158/1535-7163.c.6537582.v1
https://doi.org/10.1158/1535-7163.c.6537582.v1
Autor:
Funda Meric-Bernstam, Razelle Kurzrock, Gordon B. Mills, Geert Maertens, Erwin Sablon, Benoit Devogelaere, Sapna Patel, Bryan K. Kee, Michael J. Overman, Scott Kopetz, Rajyalakshmi Luthra, Vivek Subbiah, Ralph G. Zinner, Veronica R. Holley, Daniel D. Karp, Jennifer J. Wheler, Sarina A. Piha-Paul, Aung Naing, Apostolia M. Tsimberidou, Goran Cabrilo, Giovanni Nitti, Nishma M. Ramzanali, David Hong, Siqing Fu, Gerald S. Falchook, Bart Claes, Helen J. Huang, Filip Janku
Supplementary Table 1. Emergence of BRAF mutations in cfDNA; Supplementary Table 2. Patients with BRAF V600K mutations in FFPE tumor and plasma cfDNA samples; Supplementary Table 3. Experimental therapies in 34 patients with longitudinal collection o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a225a4b89a691edeccc2bf76884a81a5
https://doi.org/10.1158/1535-7163.22503987
https://doi.org/10.1158/1535-7163.22503987
Autor:
Marta Martin-Richard, Carlos Fernández-Martos, Veronica Fernández, Xabier García-Albéniz, José Ramón Muñoz Rodríguez, Antonieta Salud, Bart Claes, Mireia Gil-Raga, E. Falcó, Jaime Feliu, Federico Rojo, Òscar Reig, Vicente Alonso, Joan Maurel, Beatriz Bellosillo, Marta Mendiola, Jorge Aparicio, Miguel M. Méndez, Hermini Manzano, Pilar Escudero, Bart Jacobs, Ferran Torres, Clara Montagut, Javier Gallego, Erwin Sablon, Geert Maertens, Montserrat Zanui, Julen Fernández-Plana, Jose Carlos Mendez
Publikováno v:
Jco Precision Oncology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
JCO Precision Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
JCO Precision Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
PURPOSE RAS and BRAF mutations can be detected as a mechanism of acquired resistance in circulating tumor (ct) DNA in patients with metastatic colorectal cancer treated with anti–epidermal growth factor receptor therapy. METHODS RAS and BRAF mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f28688c1976de7aba93e577105de3e6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11513
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11513
Autor:
Ambre Bott, Bart Neyns, Sofie Wilgenhof, Teofila Seremet, Max Schreuer, Ines Chevolet, Yanina Jansen, Geert Maertens, Sari Van Den Herrewegen, Geert Meersseman
Publikováno v:
Melanoma Research. 26:157-163
Small fragments of cell-free DNA that are shed by normal and tumor cells can be detected in the plasma of patients with advanced melanoma. Quantitative measurement of BRAF V600 mutant DNA within the cell-free DNA holds promise as a tumor-specific bio
Autor:
J. Feliu Batlle, B.A.W. Jacobs, Jorge Aparicio, José Remesal Rodríguez, V. Fernández, A. Salud Salvia, X. García de Albéniz, Federico Rojo, Pilar Escudero, Carlos Fernández-Martos, Geert Maertens, J. Fernández-Plana, V. Alonso, J. Gallego Plazas, Marta Martin-Richard, Erwin Sablon, C. Montagut, Bart Claes, M. Méndez, Juan Maurel
Publikováno v:
Annals of oncology, 29. Oxford University Press
Publikováno v:
Personalized medicine. 5(2)
GENimmune NV is a newly created biopharmaceutical company, based in Belgium, that focuses on developing immune therapeutics against chronic infectious diseases characterized by inadequate immune responses. The company has already developed an early-s
Autor:
M. Reijans, Geert Maertens, S. Patera, S.V. Gestel, J.M. Castro Gomez, C. Gouedard, Stuart J. Murray, C. Vandesteene, E.D. Haes
Publikováno v:
Annals of Oncology. 30:v577
Background To predict the response to EGFR tyrosine kinase inhibitor (TKI) therapy in non-small cell lung cancer (NSCLC) patients, formalin-fixed paraffin-embedded (FFPE) tumor tissue is routinely tested for the presence of somatic mutations in the e